Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2025)

Historic Change in Cash for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Q3 2025 value amounting to -$83.4 million.

  • Rhythm Pharmaceuticals' Change in Cash rose 2696.66% to -$83.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 12813.79%. This contributed to the annual value of $29.2 million for FY2024, which is 14318.6% up from last year.
  • Rhythm Pharmaceuticals' Change in Cash amounted to -$83.4 million in Q3 2025, which was up 2696.66% from $29.6 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Change in Cash ranged from a high of $108.2 million in Q2 2024 and a low of -$114.1 million during Q3 2024
  • Its 5-year average for Change in Cash is -$2.6 million, with a median of -$4.5 million in 2023.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Change in Cash plummeted by 19340.04% in 2023, and later skyrocketed by 169711.11% in 2024.
  • Rhythm Pharmaceuticals' Change in Cash (Quarter) stood at -$33.1 million in 2021, then crashed by 73.32% to -$57.4 million in 2022, then surged by 92.14% to -$4.5 million in 2023, then surged by 1022.38% to $41.6 million in 2024, then plummeted by 300.31% to -$83.4 million in 2025.
  • Its Change in Cash was -$83.4 million in Q3 2025, compared to $29.6 million in Q2 2025 and $17.0 million in Q1 2025.